158 related articles for article (PubMed ID: 31319151)
1. Physiologically based ocular pharmacokinetic modeling using computational methods.
Missel PJ; Sarangapani R
Drug Discov Today; 2019 Aug; 24(8):1551-1563. PubMed ID: 31319151
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive insight on ocular pharmacokinetics.
Agrahari V; Mandal A; Agrahari V; Trinh HM; Joseph M; Ray A; Hadji H; Mitra R; Pal D; Mitra AK
Drug Deliv Transl Res; 2016 Dec; 6(6):735-754. PubMed ID: 27798766
[TBL] [Abstract][Full Text] [Related]
3. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
[TBL] [Abstract][Full Text] [Related]
4. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
Deng F; Ranta VP; Kidron H; Urtti A
Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
[TBL] [Abstract][Full Text] [Related]
5. [Ocular pharmacokinetics: Topical, intravitreal, and systemic drug application].
Meyer CH; Krohne TU
Ophthalmologe; 2014 Feb; 111(2):104-6. PubMed ID: 24510172
[No Abstract] [Full Text] [Related]
6. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.
Subrizi A; Del Amo EM; Korzhikov-Vlakh V; Tennikova T; Ruponen M; Urtti A
Drug Discov Today; 2019 Aug; 24(8):1446-1457. PubMed ID: 30738982
[TBL] [Abstract][Full Text] [Related]
7. Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products.
German C; Chen Z; Przekwas A; Walenga R; Babiskin A; Zhao L; Fan J; Tan ML
Pharm Res; 2023 Apr; 40(4):961-975. PubMed ID: 36959411
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Ocular Drug Distribution from Systemic Blood Circulation.
Vellonen KS; Soini EM; Del Amo EM; Urtti A
Mol Pharm; 2016 Sep; 13(9):2906-11. PubMed ID: 26674753
[TBL] [Abstract][Full Text] [Related]
10. [Ways to improve ocular bioavailability for topical applications].
Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
[TBL] [Abstract][Full Text] [Related]
11. Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
Gukasyan HJ; Hailu S; Karami TK; Graham R
Drug Discov Today; 2019 Aug; 24(8):1587-1597. PubMed ID: 30959112
[TBL] [Abstract][Full Text] [Related]
12. Protocol for evaluation of topical ophthalmic drug products in different compartments of fresh eye tissues in a rabbit model.
Chockalingam A; Xu L; Stewart S; LeMerdy M; Tsakalozou E; Fan J; Patel V; Rouse R
J Pharmacol Toxicol Methods; 2019; 96():9-14. PubMed ID: 30552958
[TBL] [Abstract][Full Text] [Related]
13. Computational modeling of drug transport across the in vitro cornea.
Pak J; Chen ZJ; Sun K; Przekwas A; Walenga R; Fan J
Comput Biol Med; 2018 Jan; 92():139-146. PubMed ID: 29175100
[TBL] [Abstract][Full Text] [Related]
14. In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
Mori A; Yabuta C; Kishimoto Y; Kozai S; Ohtori A; Shearer TR; Azuma M
J Ocul Pharmacol Ther; 2017 Sep; 33(7):556-566. PubMed ID: 28598703
[TBL] [Abstract][Full Text] [Related]
15. Transient analysis of ocular drug delivery: zero-volume effect.
Keister JC; Heidmann PS; Missel PJ
J Pharm Sci; 1997 Sep; 86(9):1040-5. PubMed ID: 9294819
[TBL] [Abstract][Full Text] [Related]
16. A pharmacokinetic model for ocular drug delivery.
Tojo K
Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1290-4. PubMed ID: 15516748
[TBL] [Abstract][Full Text] [Related]
17. Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation.
Le Merdy M; AlQaraghuli F; Tan ML; Walenga R; Babiskin A; Zhao L; Lukacova V
Pharm Res; 2023 Feb; 40(2):431-447. PubMed ID: 36151444
[TBL] [Abstract][Full Text] [Related]
18. Modeling the kinetics of topically applied ophthalmic agents.
Wyatt HJ
Optom Vis Sci; 1991 Aug; 68(8):663-5. PubMed ID: 1923344
[TBL] [Abstract][Full Text] [Related]
19. Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet?
Argikar UA; Dumouchel JL; Kramlinger VM; Cirello AL; Gunduz M; Dunne CE; Sohal B
J Pharm Sci; 2017 Sep; 106(9):2276-2281. PubMed ID: 28322939
[TBL] [Abstract][Full Text] [Related]
20. Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.
Le Merdy M; Spires J; Lukacova V; Tan ML; Babiskin A; Xu X; Zhao L; Bolger MB
Pharm Res; 2020 Nov; 37(12):245. PubMed ID: 33215336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
